VOLUME 9 (2018)
View Archive »
About The Cover
The cover for issue 18 of Oncotarget features Figure 1, "Schematic of experimental procedures for generation of novel anti-Sonic Hedgehog (Shh) candidate therapeutic antibodies directed at the carboxy (C)-terminal," from
Tolani, et al.
Table of Contents
Editorial
|
| Extended therapy breaks from VEGFR TKI therapy in renal cell carcinoma: Sometimes less is more |
|
https://doi.org/10.18632/oncotarget.23005
|
| 14036-14037 |
|
| Serum microRNAs – potent biomarkers for radiation biodosimetry |
|
https://doi.org/10.18632/oncotarget.24381
|
| 14038-14039 |
|
| Breast cancer cells exploit mitophagy to exert therapy resistance |
|
https://doi.org/10.18632/oncotarget.24533
|
| 14040-14041 |
Research Papers: Gerotarget (Focus on Aging)
|
| Novel inhibitor candidates of TRPV2 prevent damage of dystrophic myocytes and ameliorate against dilated cardiomyopathy in a hamster model |
|
https://doi.org/10.18632/oncotarget.24449
|
| 14042-14057 |
Research Papers
|
| Increased visceral fat volume raises the risk for recurrence of hepatocellular carcinoma after curative treatment |
|
https://doi.org/10.18632/oncotarget.24500
|
| 14058-14067 |
|
| Hypertension predicts a poor prognosis in patients with esophageal squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.23774
|
| 14068-14076 |
|
| Genetic variation of CXCR4 and risk of coronary artery disease: epidemiological study and functional validation of CRISPR/Cas9 system |
|
https://doi.org/10.18632/oncotarget.23491
|
| 14077-14083 |
|
| Cystatin A suppresses tumor cell growth through inhibiting epithelial to mesenchymal transition in human lung cancer |
|
https://doi.org/10.18632/oncotarget.23505
|
| 14084-14098 |
|
| Orthotopic hepatic cancer: radiofrequency hyperthermiaenhanced intratumoral herpes simplex virusthymidine kinase gene therapy |
|
https://doi.org/10.18632/oncotarget.23586
|
| 14099-14108 |
|
| Association analysis of SNPs present in plasma with adverse events and population pharmacokinetics in Chinese sunitinib treated patients with renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.23881
|
| 14109-14123 |
|
| AP1 confers resistance to anticancer therapy by activating XIAP |
|
https://doi.org/10.18632/oncotarget.23897
|
| 14124-14137 |
|
| Perspectives of patients and physicians about neuroendocrine tumors A qualitative study |
|
https://doi.org/10.18632/oncotarget.24347
|
| 14138-14147 |
|
| Synergistic effects of inhibiting the MNKeIF4E and PI3K/AKT/ mTOR pathways on cell migration in MDAMB231 cells |
|
https://doi.org/10.18632/oncotarget.24354
|
| 14148-14159 |
|
| Cell internalization of 7ketocholesterolcontaining nanoemulsion through LDL receptor reduces melanoma growth <i>in vitro</i> and <i>in vivo</i>: a preliminary report |
|
https://doi.org/10.18632/oncotarget.24389
|
| 14160-14174 |
|
| RUNX1 and RUNX3 protect against YAPmediated EMT stemness and shorter survival outcomes in breast cancer |
|
https://doi.org/10.18632/oncotarget.24419
|
| 14175-14192 |
|
| Molecular and clinical features of the <i>TP53</i> signature gene expression profile in earlystage breast cancer |
|
https://doi.org/10.18632/oncotarget.24447
|
| 14193-14206 |
|
| High expression of SLCO2B1 is associated with prostate cancer recurrence after radical prostatectomy |
|
https://doi.org/10.18632/oncotarget.24453
|
| 14207-14218 |
|
| Excellent outcomes of 2GTKI therapy after imatinib failure in chronic phase CML patients |
|
https://doi.org/10.18632/oncotarget.24478
|
| 14219-14227 |
|
| Interferon beta induces apoptosis in nasopharyngeal carcinoma cells via the TRAILsignaling pathway |
|
https://doi.org/10.18632/oncotarget.24479
|
| 14228-14250 |
|
| Dysregulation of fibulin5 and matrix metalloproteases in epithelial ovarian cancer |
|
https://doi.org/10.18632/oncotarget.24484
|
| 14251-14267 |
|
| Integrative proteomic and transcriptomic analysis provides evidence for TrkB NTRK2 as a therapeutic target in combination with tyrosine kinase inhibitors for nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.24361
|
| 14268-14284 |
|
| Comparative study of interhemispheric functional connectivity in left eye monocular blindness versus right eye monocular blindness: a restingstate functional MRI study |
|
https://doi.org/10.18632/oncotarget.24487
|
| 14285-14295 |
|
| Predictive value of inflammationbased prognostic scores in patients with metastatic renal cell carcinoma treated with cytoreductive nephrectomy |
|
https://doi.org/10.18632/oncotarget.24507
|
| 14296-14305 |
|
| <i>TP53</i> mutations and number of alterations correlate with maximum standardized uptake value SUVmax determined by positron emission tomography/computed tomography PET/CT [<sup>18</sup>F] fluorodeoxyglucose <sup>18</sup>FFDG PET |
|
https://doi.org/10.18632/oncotarget.24508
|
| 14306-14310 |
|
| Preclinical characterization of therapeutic antibodies targeted at the carboxyterminus of Sonic hedgehog |
|
https://doi.org/10.18632/oncotarget.24510
|
| 14311-14323 |
|
| Mandatory role of HMGA1 in human airway epithelial normal differentiation and postinjury regeneration |
|
https://doi.org/10.18632/oncotarget.24511
|
| 14324-14337 |
|
| Aberrant expression of NKL homeobox gene HLX in Hodgkin lymphoma |
|
https://doi.org/10.18632/oncotarget.24512
|
| 14338-14353 |
|
| Urinary cellfree nucleic acid IQGAP3: a new noninvasive diagnostic marker for bladder cancer |
|
https://doi.org/10.18632/oncotarget.24436
|
| 14354-14365 |
|
| Interactome analysis of transforming growth factorβactivated kinase 1 in <i>Helicobacter pylori</i>infected cells revealed novel regulators tripartite motif 28 and CDC37 |
|
https://doi.org/10.18632/oncotarget.24544
|
| 14366-14381 |
|
| MiR124 aggravates failing hearts by suppressing CD151facilitated angiogenesis in heart |
|
https://doi.org/10.18632/oncotarget.24205
|
| 14382-14396 |
|
| RhoA/Rhokinase triggers epithelialmesenchymal transition in mesothelial cells and contributes to the pathogenesis of dialysisrelated peritoneal fibrosis |
|
https://doi.org/10.18632/oncotarget.24208
|
| 14397-14412 |
|
| The protective autophagy activated by GANT61 in MYCN amplified neuroblastoma cells is mediated by PERK |
|
https://doi.org/10.18632/oncotarget.24214
|
| 14413-14427 |
|
| IRE1αXBP1 inhibitors exerted antitumor activities in Ewing's sarcoma |
|
https://doi.org/10.18632/oncotarget.24467
|
| 14428-14443 |
|
| Association between angiotensin II receptor type 1 A1166C polymorphism and chronic kidney disease |
|
https://doi.org/10.18632/oncotarget.24469
|
| 14444-14455 |
|
| Fibroblast growth factor receptor signaling plays a key role in transformation induced by the TMPRSS2/ERG fusion gene and decreased PTEN |
|
https://doi.org/10.18632/oncotarget.24470
|
| 14456-14471 |
|
| Trends in the prevalence of congenital hydrocephalus in 14 cities in Liaoning province China from 2006 to 2015 in a populationbased birth defect registry from the Liaoning Women and Children's Health Hospital |
|
https://doi.org/10.18632/oncotarget.24239
|
| 14472-14480 |
|
| Depleting ovarian cancer stem cells with calcitriol |
|
https://doi.org/10.18632/oncotarget.24520
|
| 14481-14491 |
|
| A pilot study on primary cultures of human respiratory tract epithelial cells to predict patients’ responses to H7N9 infection |
|
https://doi.org/10.18632/oncotarget.24537
|
| 14492-14508 |
|
| Novel natural withanolides induce apoptosis and inhibit migration of neuroblastoma cells through down regulation of Nmyc and suppression of Akt/mTOR/NFκB activation |
|
https://doi.org/10.18632/oncotarget.24429
|
| 14509-14523 |
|
| The circadian clock regulates cisplatininduced toxicity and tumor regression in melanoma mouse and human models |
|
https://doi.org/10.18632/oncotarget.24539
|
| 14524-14538 |
|
| Doxorubicininduced loss of DNA topoisomerase II and DNMT1 dependent suppression of MiR125b induces chemoresistance in ALKpositive cells |
|
https://doi.org/10.18632/oncotarget.24465
|
| 14539-14551 |
|
| Reduced SMAD2/3 activation independently predicts increased depth of human cutaneous squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.24545
|
| 14552-14566 |
|
| Galectin3 sensitized melanoma cell lines to vemurafenib PLX4032 induced cell death through prevention of autophagy |
|
https://doi.org/10.18632/oncotarget.24516
|
| 14567-14579 |
|
| Luminal breast cancerspecific circular RNAs uncovered by a novel tool for data analysis |
|
https://doi.org/10.18632/oncotarget.24522
|
| 14580-14596 |
|
| Calpastatin phosphorylation regulates radiationinduced calpain activity in glioblastoma |
|
https://doi.org/10.18632/oncotarget.24523
|
| 14597-14607 |
|
| Long noncoding RNA ANRIL as a novel biomarker of lymph node metastasis and prognosis in human cancer: a metaanalysis |
|
https://doi.org/10.18632/oncotarget.21825
|
| 14608-14618 |
|
| The efficacy and safety of paclitaxel and carboplatin with versus without bevacizumab in patients with nonsmallcell lung cancer: a systematic review and metaanalysis |
|
https://doi.org/10.18632/oncotarget.23657
|
| 14619-14629 |
|
| Trigger pSA predicting recurrence from positive choline PET/CT with prostate cancer after initial treatment |
|
https://doi.org/10.18632/oncotarget.24318
|
| 14630-14641 |
|
| Clinicopathological and prognostic significance of Twist overexpression in NSCLC |
|
https://doi.org/10.18632/oncotarget.24489
|
| 14642-14651 |
Clinical Research Papers
|
| Positive urinary fluorescence in situ hybridization indicates poor prognosis in patients with upper tract urothelial carcinoma |
|
https://doi.org/10.18632/oncotarget.24007
|
| 14652-14660 |
|
| Type 2 diabetes mellitusrelated changes in left ventricular structure and function in patients with chronic kidney disease |
|
https://doi.org/10.18632/oncotarget.24482
|
| 14661-14668 |
Reviews
|
| Healthy efficacy of <i>Nostoc commune</i> Vaucher |
|
https://doi.org/10.18632/oncotarget.23620
|
| 14669-14679 |
|
| Old Sonic Hedgehog new tricks: a new paradigm in thoracic malignancies |
|
https://doi.org/10.18632/oncotarget.24411
|
| 14680-14691 |
|
| Vive la radiorésistance: converging research in radiobiology and biogerontology to enhance human radioresistance for deep space exploration and colonization |
|
https://doi.org/10.18632/oncotarget.24461
|
| 14692-14722 |
|
| Prostatic cancers: understanding their molecular pathology and the 2016 WHO classification |
|
https://doi.org/10.18632/oncotarget.24515
|
| 14723-14737 |
Case Reports
|
| Immune checkpoint inhibitors in large cell neuroendocrine carcinoma: current status |
|
https://doi.org/10.18632/oncotarget.24553
|
| 14738-14740 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
